The global mycoprotein ingredients for pet food market was valued at US$420 million in 2024 and is projected to reach US$1.12 billion by 2033, expanding at a compound annual growth rate of 11.2% during the forecast period, according to a report from Research Intelo.
According to the research, the growth is driven by rising demand for sustainable, high-protein and allergen-friendly pet food alternatives as pet owners increasingly prioritize health-conscious and environmentally responsible nutrition. Consumer awareness about the environmental impact of traditional animal-based pet foods and adoption of alternative proteins are also contributing factors.
Pet humanization trends are influencing the market, with pet owners seeking high-quality, nutritious and sustainable food options similar to their own dietary choices, noted Research Intelo. Mycoprotein is a high-protein, low-fat and cholesterol-free ingredient.
Environmental considerations are pushing manufacturers to explore alternative protein sources, the company noted, stating mycoprotein production has a lower carbon footprint compared to traditional meat. Regulatory support for novel food ingredients in pet nutrition is also facilitating market expansion.
The report said the market faces challenges including high production costs and limited consumer awareness in some regions. Integrating mycoprotein into pet diets requires careful formulation to meet nutritional needs.
Advances in fermentation and bioprocessing techniques have improved yield, consistency and nutrient retention in mycoprotein production, the report added.
Companies active in the mycoprotein ingredients for pet food market include AB Agri Limited, Alltech Inc., Angel Yeast Co. Ltd., Biospringer (Lesaffre Group), Calysta Inc., Chr. Hansen Holding A/S, Corbion N.V., DuPont Nutrition & Health, EniferBio and Fermentalg.
